Skip to Main Content

Author Details

Capucine Van Rechem
Stanford University School of Medicine
2007
35
21
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37468633p53 governs an AT1 differentiation programme in lung cancer suppression.Nature2023
35243385Protocol to isolate cells in four stages of S phase for high-resolution replication-timing sequencing.STAR Protoc2022
35749589The Interaction of SWI/SNF with the Ribosome Regulates Translation and Confers Sensitivity to Translation Pathway Inhibitors in Cancers with Complex Perturbations.Cancer Res2022
36169399Phosphoproteomic mapping reveals distinct signaling actions and activation of muscle protein synthesis by Isthmin-1.Elife2022
36386876Computational workflow for integrative analyses of DNA replication timing, epigenomic, and transcriptomic data.STAR Protoc2022
35256805DNA replication fork speed underlies cell fate changes and promotes reprogramming.Nat Genet2022
35310076A cell-sorting-based protocol for cell cycle small-scale ChIP sequencing.STAR Protoc2022
34593978Author Correction: Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.Commun Biol2021
34404904Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.Commun Biol2021
34610305Collective regulation of chromatin modifications predicts replication timing during cell cycle.Cell Rep2021
32798738The lysine demethylase KDM4A controls the cell-cycle expression of replicative canonical histone genes.Biochim Biophys Acta Gene Regul Mech2020
30612740METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.Cell2019
31399344The Histone Deacetylase SIRT6 Restrains Transcription Elongation via Promoter-Proximal Pausing.Mol Cell2019
30500540Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications.Cell2018
30057114Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications.Cell2018
29233476E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression.Dev Cell2017
25564516Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.Cancer Discov2015
25995187Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.Genes Dev2015
25646486Retraction for Zhang et al., Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex.Proc Natl Acad Sci U S A2015
25564517A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.Cancer Discov2015
24859469Examining the impact of gene variants on histone lysine methylation.Biochim Biophys Acta2014
23178572Identification of p21 (CIP1/WAF1) as a direct target gene of HIC1 (Hypermethylated In Cancer 1).Biochem Biophys Res Commun2013
23871696KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.Cell2013
22184117The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).J Biol Chem2012
23200123Histone lysine methylation dynamics: establishment, regulation, and biological impact.Mol Cell2012
22458515The transcription factor encyclopedia.Genome Biol2012
22315224Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.J Biol Chem2012
22194601Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.J Biol Chem2012
21757720The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein.J Biol Chem2011
20547755Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.Mol Cell Biol2010
21145482Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression.Mol Cell2010
18723112HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.Int J Biochem Cell Biol2009
19525223Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).J Biol Chem2009
19486893HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A.Biochem Biophys Res Commun2009
17213307Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex.Proc Natl Acad Sci U S A2007
  • 1 - 35 of 35

Recommended Authors

Queen's University
Career Start Year 2011
Number of shared co-authors 0
University of North Carolina
Career Start Year 2010
Number of shared co-authors 0
Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
College of Medicine, University of Glasgow
Career Start Year 2010
Number of shared co-authors 0
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 0
Van Andel Institute
Career Start Year 2009
Number of shared co-authors 2
The Francis Crick Institute
Career Start Year 2008
Number of shared co-authors 0
Center for Public Health Genomics, University of Virginia
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 2006
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 3
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year 2003
Number of shared co-authors 0
Institute of Cellular and Organismic Biology
Career Start Year 2003
Number of shared co-authors 0
The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year 2003
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2001
Number of shared co-authors 2
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 6
Stanford University
Career Start Year 2001
Number of shared co-authors 1
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Career Start Year 2000
Number of shared co-authors 3
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1999
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Salk Institute for Biological Studies
Career Start Year 1998
Number of shared co-authors 1
Institute for Cancer Genetics, Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 1
University of North Carolina
Career Start Year 1996
Number of shared co-authors 5
Radboud Institute for Molecular Science, Radboud University
Career Start Year 1995
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1994
Number of shared co-authors 6
Northwestern University Feinberg School of Medicine
Career Start Year 1991
Number of shared co-authors 2
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 1
Centre Hospitalier Universitaire (CHU) de Quebec-Universite Laval Research Center
Career Start Year 1987
Number of shared co-authors 2
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1987
Number of shared co-authors 1
Penn Epigenetics Institute, Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 3

Collaborators

University Lille, CNRS, INSERM
Co-authored papers 11
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 8
Brain Tumor Institute, Children's National Hospital
Co-authored papers 4
Co-authored papers 4
Co-authored papers 2
Center for Genomics and Systems Biology, New York University
Co-authored papers 2
Co-authored papers 2
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 2
Vollum Institute, Oregon Health & Science University
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Addenbrooke's Hospital, University of Cambridge
Co-authored papers 1
The Rockefeller University
Co-authored papers 1
Institute of Epigenetics and Stem Cells (IES)
Co-authored papers 1
Stanford University
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Universidade da Coruna
Co-authored papers 1
Stanford University School of Medicine
Co-authored papers 1
McGill University
Co-authored papers 1
University of Virginia
Co-authored papers 1
university of california san diego School of Medicine, University of California
Co-authored papers 1
Stanford University Medical Center
Co-authored papers 1
Centre affilie a l'Universite de Montreal
Co-authored papers 1
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers 1
The Institute of Cancer Research
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute, Harvard School of Public Health
Co-authored papers 1
the Rockefeller University
Co-authored papers 1
Co-authored papers 1
University of California riverside
Co-authored papers 1